Beta Bionics Inc.

NASDAQ: BBNX · Real-Time Price · USD
17.04
0.33 (1.97%)
At close: Aug 15, 2025, 3:59 PM
17.04
0.03%
After-hours: Aug 15, 2025, 05:33 PM EDT

Beta Bionics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Revenue
23.24M 17.64M 20.44M 16.7M 15.05M 12.93M 8.35M 3.09M
Cost of Revenue
10.73M 8.67M 8.75M 7.79M 6.96M 5.73M 3.29M 1.87M
Gross Profit
12.5M 8.97M 11.69M 8.91M 8.08M 7.2M 5.06M 1.23M
Operating Income
-19.87M -18.64M -13.04M -10.98M -11.78M -9.45M -8.37M -8.78M
Interest Income
3M 2.44M 951K 826K 993K 1.14M n/a n/a
Pretax Income
-16.87M -28.66M -18.11M -9.74M -14.46M -12.45M -18.85M -8.68M
Net Income
-16.87M -28.66M -18.11M -9.74M -14.46M -12.45M -18.85M -8.68M
Selling & General & Admin
23.5M 20.02M 15.51M 14.75M 13.52M 11.18M 8.97M 6.15M
Research & Development
8.87M 7.59M 9.21M 5.14M 6.35M 5.48M 4.46M 3.85M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
32.38M 27.61M 24.73M 19.89M 19.87M 16.65M 13.43M 10.01M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
15.62M 13.4M 10.8M 9.64M 8.97M 7.66M 5.62M 3.33M
Cost & Expenses
43.11M 36.28M 33.48M 27.68M 26.83M 22.39M 16.72M 11.88M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
43.39M 30.71M 43.35M 6.26M 43.35M 30.5M 6.03M 5.06M
Shares Outstanding (Diluted)
43.39M 30.71M 43.35M 6.26M 43.35M 30.5M 6.03M 5.06M
EPS (Basic)
-0.39 -0.93 -0.42 -1.55 -0.33 -0.41 -3.13 -1.71
EPS (Diluted)
-0.39 -0.93 -0.42 -1.55 -0.33 -0.41 -3.13 -1.71
EBITDA
-19.87M -18.04M -17.58M -10.67M -13.89M -8.89M -8.07M -8.47M
EBIT
-16.87M -18.64M -18.11M -10.98M -14.46M -9.45M -8.37M -8.78M
Depreciation & Amortization
653K 604K 529K 306.33K 576K 563K 292K 311.33K